In human breast cancer MCF-7 and MDA-MB-231 cells, leptin treatment promoted VEGF secretion and increased cell proliferation and migration compared to controls, whereas treatment with adiponectin exerted the opposite effect [21]. The gene discussed is LEP; the disease is breast cancer.